FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:RCOR3-KCNH1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: RCOR3-KCNH1
FusionPDB ID: 73336
FusionGDB2.0 ID: 73336
HgeneTgene
Gene symbol

RCOR3

KCNH1

Gene ID

55758

3756

Gene nameREST corepressor 3potassium voltage-gated channel subfamily H member 1
Synonyms-EAG|EAG1|Kv10.1|TMBTS|ZLS1|h-eag|hEAG|hEAG1
Cytomap

1q32.2-q32.3

1q32.2

Type of geneprotein-codingprotein-coding
DescriptionREST corepressor 3potassium voltage-gated channel subfamily H member 1EAG channel 1ether-a-go-go 1ether-a-go-go potassium channel 1ether-a-go-go, Drosophila, homolog ofpotassium channel, voltage gated eag related subfamily H, member 1potassium voltage-gated channel,
Modification date2020032720200313
UniProtAcc.

O95259

Main function of 5'-partner protein: FUNCTION: Pore-forming (alpha) subunit of a voltage-gated delayed rectifier potassium channel (PubMed:9738473, PubMed:11943152, PubMed:10880439, PubMed:22732247, PubMed:25556795, PubMed:27325704, PubMed:27005320, PubMed:27618660). Channel properties are modulated by subunit assembly (PubMed:11943152). Mediates IK(NI) current in myoblasts (PubMed:9738473). Involved in the regulation of cell proliferation and differentiation, in particular adipogenic and osteogenic differentiation in bone marrow-derived mesenchymal stem cells (MSCs) (PubMed:23881642). {ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:11943152, ECO:0000269|PubMed:22732247, ECO:0000269|PubMed:23881642, ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:27005320, ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660, ECO:0000269|PubMed:9738473}.
Ensembl transtripts involved in fusion geneENST idsENST00000367005, ENST00000367006, 
ENST00000419091, ENST00000452621, 
ENST00000526255, 
ENST00000271751, 
ENST00000367007, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score4 X 4 X 4=646 X 5 X 6=180
# samples 46
** MAII scorelog2(4/64*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/180*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: RCOR3 [Title/Abstract] AND KCNH1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: RCOR3 [Title/Abstract] AND KCNH1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)RCOR3(211469095)-KCNH1(211192598), # samples:1
Anticipated loss of major functional domain due to fusion event.RCOR3-KCNH1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
RCOR3-KCNH1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
RCOR3-KCNH1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
RCOR3-KCNH1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneKCNH1

GO:0071805

potassium ion transmembrane transport

22732247|27005320|27325704



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:211469095/chr1:211192598)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across RCOR3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KCNH1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000367006RCOR3chr1211469095+ENST00000271751KCNH1chr1211192598-3779129928237101142
ENST00000367006RCOR3chr1211469095+ENST00000367007KCNH1chr1211192598-3673129928236291115
ENST00000452621RCOR3chr1211469095+ENST00000271751KCNH1chr1211192598-3670119017336011142
ENST00000452621RCOR3chr1211469095+ENST00000367007KCNH1chr1211192598-3564119017335201115
ENST00000419091RCOR3chr1211469095+ENST00000271751KCNH1chr1211192598-3625114512835561142
ENST00000419091RCOR3chr1211469095+ENST00000367007KCNH1chr1211192598-3519114512834751115
ENST00000367005RCOR3chr1211469095+ENST00000271751KCNH1chr1211192598-346498414133951084
ENST00000367005RCOR3chr1211469095+ENST00000367007KCNH1chr1211192598-335898414133141057

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000367006ENST00000271751RCOR3chr1211469095+KCNH1chr1211192598-0.0003836430.9996164
ENST00000367006ENST00000367007RCOR3chr1211469095+KCNH1chr1211192598-0.0012206960.99877936
ENST00000452621ENST00000271751RCOR3chr1211469095+KCNH1chr1211192598-0.000379340.9996207
ENST00000452621ENST00000367007RCOR3chr1211469095+KCNH1chr1211192598-0.0012221430.9987778
ENST00000419091ENST00000271751RCOR3chr1211469095+KCNH1chr1211192598-0.0003552690.99964476
ENST00000419091ENST00000367007RCOR3chr1211469095+KCNH1chr1211192598-0.0011515760.99884844
ENST00000367005ENST00000271751RCOR3chr1211469095+KCNH1chr1211192598-0.0002060220.99979395
ENST00000367005ENST00000367007RCOR3chr1211469095+KCNH1chr1211192598-0.0007327010.9992673

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for RCOR3-KCNH1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
RCOR3chr1211469095KCNH1chr12111925981145339KMEGGIEEFKPPEVLQLGSDILPQYK
RCOR3chr1211469095KCNH1chr12111925981190339KMEGGIEEFKPPEVLQLGSDILPQYK
RCOR3chr1211469095KCNH1chr12111925981299339KMEGGIEEFKPPEVLQLGSDILPQYK
RCOR3chr1211469095KCNH1chr1211192598984281KMEGGIEEFKPPEVLQLGSDILPQYK

Top

Potential FusionNeoAntigen Information of RCOR3-KCNH1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
RCOR3-KCNH1_211469095_211192598.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B45:01EEFKPPEV0.99990.9656614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:02EEFKPPEV0.99990.7557614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:01EEFKPPEV0.99730.9406614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:01EEFKPPEV0.99590.8945614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B45:01IEEFKPPEV0.9990.9066514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:24FKPPEVLQL0.99860.5221817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B13:01EEFKPPEVL0.99740.9752615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:02EEFKPPEVL0.99660.6978615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:01FKPPEVLQL0.99540.9552817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:03EEFKPPEVL0.99390.9838615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:13FKPPEVLQL0.98680.9686817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:02FKPPEVLQL0.98480.9787817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:01FKPPEVLQL0.98460.977817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B47:01EEFKPPEVL0.98340.7621615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:01EEFKPPEVL0.98320.9143615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:02EEFKPPEVL0.98320.9143615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:01EEFKPPEVL0.98180.9802615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B45:01EEFKPPEVL0.97920.9603615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:02FKPPEVLQL0.96990.9106817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:01FKPPEVLQL0.96990.9106817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:10FKPPEVLQL0.96180.7489817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:37FKPPEVLQL0.80950.8766817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:01IEEFKPPEV0.80830.8259514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:13EEFKPPEVL0.77910.9694615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:01EEFKPPEVL0.74250.9689615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:01EEFKPPEVL0.74030.9756615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:02EEFKPPEVL0.72550.9819615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:01IEEFKPPEV0.65150.7449514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:37EEFKPPEVL0.61320.8662615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:01EEFKPPEVL0.55930.9141615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:10EEFKPPEVL0.50450.8172615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:01EEFKPPEVL0.48650.7775615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:13IEEFKPPEV0.13630.8741514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:13IEEFKPPEVL0.90630.9613515
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:03EEFKPPEVLQL0.9990.9318617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B48:01GIEEFKPPEVL0.99810.6535415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B47:01GIEEFKPPEVL0.99470.761415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:13GIEEFKPPEVL0.92610.9849415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:06EEFKPPEV10.6848614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B51:07EEFKPPEV0.96670.9842614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:30KPPEVLQL0.96030.9165917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:17KPPEVLQL0.92950.8952917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:10KPPEVLQL0.66250.9021917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:06IEEFKPPEV0.99980.5515514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:06EEFKPPEVL0.99930.6354615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:10EEFKPPEVL0.99830.6663615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:09FKPPEVLQL0.99820.7661817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:12FKPPEVLQL0.99270.9601817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:05FKPPEVLQL0.98870.9476817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:05FKPPEVLQL0.9840.9689817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:27FKPPEVLQL0.97880.9706817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:95FKPPEVLQL0.97010.7674817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:13FKPPEVLQL0.95910.9607817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C03:14FKPPEVLQL0.93580.988817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:29FKPPEVLQL0.92390.9552817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C08:03FKPPEVLQL0.87610.9897817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:19FKPPEVLQL0.83870.887817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C08:13FKPPEVLQL0.83610.981817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C08:04FKPPEVLQL0.83610.981817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C03:19FKPPEVLQL0.83470.9944817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:10FKPPEVLQL0.83330.9827817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:80FKPPEVLQL0.82760.9798817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:67FKPPEVLQL0.82760.9798817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:08EEFKPPEVL0.81530.866615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:03EEFKPPEVL0.80.8979615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:09EEFKPPEVL0.79720.7879615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:46FKPPEVLQL0.78250.9545817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:05EEFKPPEVL0.7550.9638615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:06FKPPEVLQL0.71010.9593817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:12EEFKPPEVL0.70740.9717615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:17FKPPEVLQL0.62650.9078817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:08IEEFKPPEV0.62110.7657514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:07FKPPEVLQL0.61010.8284817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:10FKPPEVLQL0.60580.8362817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B14:03FKPPEVLQL0.59870.8347817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:14FKPPEVLQL0.58390.896817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C02:06FKPPEVLQL0.54960.9712817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:30FKPPEVLQL0.53290.9289817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C06:03FKPPEVLQL0.45920.9951817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C12:12FKPPEVLQL0.45810.9413817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C12:04FKPPEVLQL0.44890.9954817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C12:16FKPPEVLQL0.36570.9716817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B51:07EEFKPPEVL0.13250.9329615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:08IEEFKPPEVL0.97310.7994515
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:03GIEEFKPPEVL0.9990.6075415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:10EEFKPPEVLQL0.99890.565617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:10GIEEFKPPEVL0.99180.6398415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:08GIEEFKPPEVL0.98360.9381415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04EEFKPPEV0.99990.8334614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03EEFKPPEV0.99750.7519614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:08EEFKPPEV0.99630.9727614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:05EEFKPPEV0.99590.8945614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:03EEFKPPEV0.99530.891614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:06EEFKPPEV0.99530.9349614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:11EEFKPPEV0.99220.802614
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:02KPPEVLQL0.88150.8923917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:03KPPEVLQL0.81850.9038917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04EFKPPEVL0.73810.7967715
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B67:01KPPEVLQL0.72210.83917
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04EEFKPPEVL0.99960.7808615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04IEEFKPPEV0.99790.7646514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:31FKPPEVLQL0.99580.9563817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:02FKPPEVLQL0.99530.9673817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:07EEFKPPEVL0.99390.9838615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:13EEFKPPEVL0.99390.9838615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:26EEFKPPEVL0.99390.9838615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:07EEFKPPEVL0.98560.9648615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:05FKPPEVLQL0.98460.977817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:04EEFKPPEVL0.98330.9829615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:05EEFKPPEVL0.98180.9802615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:08EEFKPPEVL0.98040.9758615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:06EEFKPPEVL0.97690.9826615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:01FKPPEVLQL0.96740.771817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:03EEFKPPEVL0.94340.979615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:11EEFKPPEVL0.93440.9412615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:22FKPPEVLQL0.91310.7569817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:17FKPPEVLQL0.90130.9812817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:09FKPPEVLQL0.90090.7779817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C03:67FKPPEVLQL0.88420.9889817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C08:01FKPPEVLQL0.87610.9897817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03EEFKPPEVL0.83950.6406615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:02FKPPEVLQL0.82760.9798817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:11EEFKPPEVL0.78390.8304615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C07:04FKPPEVLQL0.78370.9372817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:31EEFKPPEVL0.77280.969615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:02EEFKPPEVL0.77180.9706615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03IEEFKPPEV0.74150.605514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B38:05EEFKPPEVL0.74030.9756615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:04FKPPEVLQL0.72550.9519817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C16:04FKPPEVLQL0.71180.9841817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:04IEEFKPPEV0.65150.7449514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:05IEEFKPPEV0.65150.7449514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C03:06FKPPEVLQL0.64750.9948817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:11FKPPEVLQL0.63910.7273817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C06:08FKPPEVLQL0.6330.9911817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C04:01FKPPEVLQL0.61010.8284817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:02FKPPEVLQL0.59640.9065817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C18:01FKPPEVLQL0.58680.8201817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C06:06FKPPEVLQL0.55240.9884817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C12:03FKPPEVLQL0.52190.9857817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B48:02EEFKPPEVL0.51490.974615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C01:03FKPPEVLQL0.51420.9329817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:04EEFKPPEVL0.48650.7775615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B50:05EEFKPPEVL0.48650.7775615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C12:02FKPPEVLQL0.47620.977817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C06:17FKPPEVLQL0.37960.9948817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-C06:02FKPPEVLQL0.37960.9948817
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:09EEFKPPEVL0.36350.6092615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B35:20EEFKPPEVL0.31520.9809615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:02IEEFKPPEV0.1550.882514
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B15:53EEFKPPEVL0.06650.949615
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04IEEFKPPEVL0.99740.7704515
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:02IEEFKPPEVL0.94470.9621515
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03IEEFKPPEVL0.83390.6073515
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04EEFKPPEVLQL0.99930.74617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:07EEFKPPEVLQL0.9990.9318617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:26EEFKPPEVLQL0.9990.9318617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B44:13EEFKPPEVLQL0.9990.9318617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B40:04GIEEFKPPEVL0.98230.7852415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03GIEEFKPPEVL0.97830.7516415
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B41:03EEFKPPEVLQL0.96330.5715617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B18:03EEFKPPEVLQL0.96310.8184617
RCOR3-KCNH1chr1211469095chr1211192598984HLA-B39:02GIEEFKPPEVL0.94350.9841415

Top

Potential FusionNeoAntigen Information of RCOR3-KCNH1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
RCOR3-KCNH1_211469095_211192598.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1501MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1501EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1503MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1503EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1504MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1504EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1505MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1505EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1506MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1506EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1507MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1507EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1509MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1509EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1512MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1512EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1513MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1513EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1516MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1516EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1520MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1520EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1522MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1522EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1523MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1523EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1524MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1524EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1528MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1528EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1532MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1532EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1533MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1533EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1535MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1535EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1537MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1537EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1540MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1540EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1541MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1541EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1542MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1542EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1543MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1543EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1545MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1545EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1546MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1546EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1548MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1548EGGIEEFKPPEVLQL217
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1549MEGGIEEFKPPEVLQ116
RCOR3-KCNH1chr1211469095chr1211192598984DRB1-1549EGGIEEFKPPEVLQL217

Top

Fusion breakpoint peptide structures of RCOR3-KCNH1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
1657EEFKPPEVLQLGSDRCOR3KCNH1chr1211469095chr1211192598984

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of RCOR3-KCNH1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN1657EEFKPPEVLQLGSD-7.9962-8.1096
HLA-B14:023BVN1657EEFKPPEVLQLGSD-5.70842-6.74372
HLA-B52:013W391657EEFKPPEVLQLGSD-6.83737-6.95077
HLA-B52:013W391657EEFKPPEVLQLGSD-4.4836-5.5189
HLA-A11:014UQ21657EEFKPPEVLQLGSD-10.0067-10.1201
HLA-A11:014UQ21657EEFKPPEVLQLGSD-9.03915-10.0745
HLA-A24:025HGA1657EEFKPPEVLQLGSD-6.56204-6.67544
HLA-A24:025HGA1657EEFKPPEVLQLGSD-5.42271-6.45801
HLA-B44:053DX81657EEFKPPEVLQLGSD-7.85648-8.89178
HLA-B44:053DX81657EEFKPPEVLQLGSD-5.3978-5.5112
HLA-A02:016TDR1657EEFKPPEVLQLGSD-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of RCOR3-KCNH1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
RCOR3-KCNH1chr1211469095chr1211192598415GIEEFKPPEVLGGAATTGAAGAATTCAAACCTCCTGAGGTCCTA
RCOR3-KCNH1chr1211469095chr1211192598514IEEFKPPEVATTGAAGAATTCAAACCTCCTGAGGTC
RCOR3-KCNH1chr1211469095chr1211192598515IEEFKPPEVLATTGAAGAATTCAAACCTCCTGAGGTCCTA
RCOR3-KCNH1chr1211469095chr1211192598614EEFKPPEVGAAGAATTCAAACCTCCTGAGGTC
RCOR3-KCNH1chr1211469095chr1211192598615EEFKPPEVLGAAGAATTCAAACCTCCTGAGGTCCTA
RCOR3-KCNH1chr1211469095chr1211192598617EEFKPPEVLQLGAAGAATTCAAACCTCCTGAGGTCCTACAGCTG
RCOR3-KCNH1chr1211469095chr1211192598715EFKPPEVLGAATTCAAACCTCCTGAGGTCCTA
RCOR3-KCNH1chr1211469095chr1211192598817FKPPEVLQLTTCAAACCTCCTGAGGTCCTACAGCTG
RCOR3-KCNH1chr1211469095chr1211192598917KPPEVLQLAAACCTCCTGAGGTCCTACAGCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
RCOR3-KCNH1chr1211469095chr1211192598116MEGGIEEFKPPEVLQATGGAAGGTGGAATTGAAGAATTCAAACCTCCTGAGGTCCTACAG
RCOR3-KCNH1chr1211469095chr1211192598217EGGIEEFKPPEVLQLGAAGGTGGAATTGAAGAATTCAAACCTCCTGAGGTCCTACAGCTG

Top

Information of the samples that have these potential fusion neoantigens of RCOR3-KCNH1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECRCOR3-KCNH1chr1211469095ENST00000367005chr1211192598ENST00000271751TCGA-AX-A2HF-01A

Top

Potential target of CAR-T therapy development for RCOR3-KCNH1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411449_4700990.0IntramembranePore-forming%3B Name%3DSegment H5
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411449_4700963.0IntramembranePore-forming%3B Name%3DSegment H5
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411221_2410990.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411249_2690990.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411291_3090990.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411346_3680990.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411378_3990990.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNH1chr1:211469095chr1:211192598ENST00000271751411478_4980990.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411221_2410963.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411249_2690963.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411291_3090963.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411346_3680963.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411378_3990963.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNH1chr1:211469095chr1:211192598ENST00000367007411478_4980963.0TransmembraneHelical%3B Name%3DSegment S6

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to RCOR3-KCNH1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to RCOR3-KCNH1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource